tiprankstipranks
Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market
Holding SKYE?
Track your performance easily

Skye Bioscience (SKYE) Income Statement

209 Followers

Skye Bioscience Income Statement

Last quarter (Q3 2024), Skye Bioscience's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Skye Bioscience's net income was $-3.90M. See Skye Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
------
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 11.31M$ 34.74M$ 18.31M$ 7.85M$ 6.29M$ 6.63M
Operating Income
$ -23.61M$ -34.74M$ -18.31M$ -7.85M$ -6.29M$ -6.63M
Net Non Operating Interest Income Expense
$ 1.50M$ -806.30K$ 766.35K$ -769.16K$ -706.36K$ 8.41M
Other Income Expense
$ -23.79M$ -23.16M$ -6.60M$ -139.12K$ 436.27K$ 725.42K
Pretax Income
$ -21.23M$ -37.64M$ -19.47M$ -8.52M$ -6.56M$ 1.05M
Tax Provision
$ 6.07K$ 3.60K$ 6.74K$ 2.10K$ 1.60K$ 1.60K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -21.24M$ -37.64M$ -19.48M$ -8.52M$ -6.56M$ 1.05M
Basic EPS
$ -0.51$ -5.37$ -10.00$ -5.00$ -7.50$ 2.50
Diluted EPS
$ -0.51$ -5.37$ -10.00$ -5.00$ -7.50$ -12.50
Basic Average Shares
$ 117.98M$ 7.01M$ 2.22M$ 1.63M$ 922.99K$ 540.62K
Diluted Average Shares
$ 117.98M$ 7.01M$ 2.22M$ 1.63M$ 925.68K$ 678.24K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 11.31M$ 34.74M$ 12.11M$ 7.85M$ 6.29M$ 6.63M
Net Income From Continuing And Discontinued Operation
$ -21.24M$ -37.64M$ -19.48M$ -8.52M$ -6.56M$ 1.05M
Normalized Income
$ -11.75M--$ -6.73M--
Interest Expense
------
EBIT
$ 31.67M$ 6.51M$ -18.81M$ -7.75M$ -5.85M$ 2.05M
EBITDA
$ 32.65M$ 6.97M$ -18.69M$ -7.72M$ -5.85M$ 2.68M
Currency in USD

Skye Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis